Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Randomized Controlled Clinical Trial Comparing a 24Week Oral Regimen Containing Moxifloxacin With a 24 Week Standard Drug Regimen for the Treatment of Smear-positive Pulmonary Tuberculosis in Patients Previously Treated for TB

NCT02114684 is registered in ClinicalTrials.gov with Centre for the AIDS Programme of Research in South Africa as lead sponsor.

NCT NCT02114684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02114684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Randomized Controlled Clinical Trial Comparing a 24Week Oral Regimen Containing Moxifloxacin With a 24 Week Standard Drug Regimen for the Treatment of Smear-positive Pulmonary Tuberculosis in Patients Previously Treated for TB
Lead sponsor
Centre for the AIDS Programme of Research in South Africa
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2013
Completion date
July 17, 2017
Enrollment
197 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent tuberculosis